ArticleBMC bioinformatics2023
Analysis of RNA-Seq data using self-supervised learning for vital status prediction of colorectal cancer patients.
Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- Reliable RNA-seq analysis from FFPE specimens as a means to accelerate cancer-related health disparities research.PloS one · 2025Article
- Constructing a predictive model for early-onset sepsis in neonatal intensive care unit newborns based on SHapley Additive exPlanations explainable machine learning.Translational pediatrics · 2024Article
- Review
- Potential of GSPT1 as a novel target for glioblastoma therapy.Cell death & disease · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRNA sequencing (RNA-Seq) is a technique that utilises the capabilities of next-generation sequencing to study a cellular transcriptome i.e., to determine the amount of RNA at a given time for a given biological sample. The advancement of RNA-Seq technology has resulted in a large volume of gene expression data for analysis.
resultsOur computational model (built on top of TabNet) is first pretrained on an unlabelled dataset of multiple types of adenomas and adenocarcinomas and later fine-tuned on the labelled dataset, showing promising results in the context of the estimation of the vital status of colorectal cancer patients. We achieve a final cross-validated (ROC-AUC) Score of 0.88 by using multiple modalities of data.
conclusionThe results of this study demonstrate that self-supervised learning methods pretrained on a vast corpus of unlabelled data outperform traditional supervised learning methods such as XGBoost, Neural Networks, and Decision Trees that have been prevalent in the tabular domain. The results of this study are further boosted by the inclusion of multiple modalities of data pertaining to the patients in question. We find that genes such as RBM3, GSPT1, MAD2L1, and others important to the computation model's prediction task obtained through model interpretability corroborate with pathological evidence in current literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.